Загрузка...
Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties
Orally active, selective inhibitors of phosphodiesterase type 5 (PDE 5, cyclic GMP PDE), such as sildenafil, tadalafil and vardenafil, are currently the first-choice treatment options for the clinical management of erectile dysfunction (ED) of various etiologies and severities. However, a significan...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3547533/ https://ncbi.nlm.nih.gov/pubmed/23372609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287212466282 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|